Ras oncoproteins in human plasma from lung cancer patients and healthy controls

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 349, Issue 1, 1996, Pages 121-126

  Anderson, D ^a   Hughes, J A ^a   Cebulska Wasilewska, A ^b   Nizankowska, E ^c   Graca, B ^c  

^a BIBRA INTERNATIONAL   (United Kingdom)

^b INP   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Lung cancer; Oncoprotein; Ras

Indexed keywords

ONCOPROTEIN; RAS PROTEIN;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG CANCER; MALE; PLASMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RAS PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029671213     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(95)00168-9     Document Type: Article

References (20)

1. Barbacid, M. (1987) Ras genes. Annu. Rev. Biochem., 56, 779-827.
2. Bishop, J.M. (1987) The molecular genetics of cancer. Science, 235, 305-311.
3. Bishop, J.M. (1991) Molecular themes in oncogenesis. Cell, 64, 235-248.
4. Bos, J.H. (1989) Ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
5. Brandt-Rauf, P.W. (1991) Advances in cancer biomarkers as applied to chemical exposures: the ras oncogene and p21 protein and pulmonary carcinogenesis. J. Occup. Med., 33, 951-955.
6. Brinkworth, M.H. et al. (1992) A comparison of smokers and non-smokers with respect to oncogene products and cytogenetic parameters. J. Occup. Med., 34, 1181-1188.
7. Finkelstein, S.D. et al. (1993) Genotypic classification of colorectal adenocarcinoma: biologic behaviour correlates with K-ras-2 mutation type. Cancer, 71, 3827-3838.
8. Kellen, J.A. (1995) Molecular interrelationships in multidrug resistance. Anticancer Res., 14, 433-435.
9. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680.
10. Levine, A.J. et al. (1991) The p53 tumour suppressor gene. Nature, 351, 453-456.
11. Levine, A.J. et al. (1994) The 1993 Walter Hubert lecture: the role of p53 tumour-suppressor gene in tumorigenesis. Br. J. Cancer, 69, 409-416.
12. Lowry, O.H. et al. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem., 193, 265-275.
13. Luo, J.C. et al. (1994) Detecting serum p53 protein in lung cancer patients. J. Occup. Med., 36, 155-160.
14. Malkin, D. (1994) Germline p53 gene mutations and cancer -Pandora's box or open sesame? J. Natl. Cancer Inst., 86, 326-328.
15. Perera, F.P. et al. (1992) Molecular and genetic damage in humans from environmental pollution in Poland. Nature, 35, 256-258.
16. Pimental, E. (1989) Oncogenes, CRC, Boca Raton, FL.
17. Scambia, G. et al. (1994) Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. Br. J. Cancer, 69, 995-999.
18. Slebos, R.J.C. et al. (1994) K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. New Engl. J. Med., 323, 561-565.
19. Sugio, K. et al. (1994) K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res., 54, 5811-5815.
20. Towbin, H. et al. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76, 4350.